Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach.
De Haven Brandon, A
van Montfort, RL
MetadataShow full item record
Monopolar spindle 1 (MPS1) plays a central role in the transition of cells from metaphase to anaphase and is one of the main components of the spindle assembly checkpoint. Chromosomally unstable cancer cells rely heavily on MPS1 to cope with the stress arising from abnormal numbers of chromosomes and centrosomes and are thus more sensitive to MPS1 inhibition than normal cells. We report the discovery and optimization of a series of new pyrido[3,4-d]pyrimidine based inhibitors via a structure-based hybridization approach from our previously reported inhibitor CCT251455 and a modestly potent screening hit. Compounds in this novel series display excellent potency and selectivity for MPS1, which translates into biomarker modulation in an in vivo human tumor xenograft model.
Version of record
Clinical Pharmacology & Trials (including Drug Metabolism & Pharmacokinetics Group)
Drug Target Discovery
Medicinal Chemistry 1 (including Analytical Chemistry and In Silico Chemistry)
Medicinal Chemistry 4
Hit Discovery & Structural Design
Structure-Based Drug Design
License start date
Journal of medicinal chemistry, 2016, 59 (8), pp. 3671 - 3688